Skip to main content
. Author manuscript; available in PMC: 2012 Dec 5.
Published in final edited form as: Clin Pharmacol Ther. 2010 Dec 22;89(2):276–282. doi: 10.1038/clpt.2010.307

Table 1.

Clinical characteristics of the subjects

Placebo Active P value
n 30     30    
Age (years), mean (SD) 37.5 (7.2)   37.0 (7.2)   0.75
Male, n (%) 19 (63%) 15 (50%) 0.43
Caucasian, n (%) 21 (70%) 20 (67%) 1
Smoking as primary route of administration, n (%) 20 (67%) 24 (80%) 0.38
AWQ withdrawal score (0–40), mean (SD) 14.9 (6.9)   14.6 (8.0)   0.72
ADHD diagnosis, n (%) 4 (13%) 5 (17%) 1

ADHD, attention deficit hyperactivity disorder; AWQ, Amphetamine Withdrawal Questionnaire.